Apolipoprotein mimetics in the management of human disease. (2015)
- Record Type:
- Book
- Title:
- Apolipoprotein mimetics in the management of human disease. (2015)
- Main Title:
- Apolipoprotein mimetics in the management of human disease
- Further Information:
- Note: G.M. Anantharamaiah, Dennis Goldberg, editors.
- Editors:
- Anantharamaiah, G. M (Gattadahalli Manjunath), 1947-
Goldberg, Dennis Ian, 1948- - Contents:
- Preface; Abbreviations; Contents; Introduction; The Structure and Function of Apolipoprotein Mimetic Peptides; Bibliography; The Editors; HDL and the Amphipathic Helix; Discovery, Isolation, and Characterization of HDL; Early History of HDL Structure; Discovery of the Amphipathic Helix: An Untold Story; The Amphipathic Helix and HDL; Current History of HDL Structure; Current Thoughts on the Biomedical Implications of HDL; What Are Peptide Mimetics and Should I Care?; References; ApoA-I Mimetic Peptides: A Review of the Present Status. ApoA-I Mimetic Peptides Were Designed to Mimic a Plasma Apolipoprotein The Peptides Were Effective in a Large Number of Animal Models of Disease; The 4F Peptide Was Tested in Human Clinical Trials; Reconciling the Divergent Results from the Clinical Trials; Overcoming the Barrier of the High Cost of Production of Chemically Synthesized ApoA-I Mimetic Peptides; Determining the Mechanism of Action of Oral ApoA-I Mimetic Peptides; Other Peptides; Conclusions; References; Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux; Introduction; Reverse Cholesterol Transport Pathway. Apolipoprotein Mimetic PeptidesESP24218 Peptide; D-4F Peptide; L-4F Peptide; Retroinverso Peptides; 5A Peptide; ATI-5261 Peptide; Summary; References; ApoA-I Mimetic Peptides and Diabetes; Introduction; 4F Background; 4F and Diabetes; Conclusion; References; Apolipoprotein A-I Mimetic Peptides in Mouse Models of Cancer; Introduction; Inflammation andPreface; Abbreviations; Contents; Introduction; The Structure and Function of Apolipoprotein Mimetic Peptides; Bibliography; The Editors; HDL and the Amphipathic Helix; Discovery, Isolation, and Characterization of HDL; Early History of HDL Structure; Discovery of the Amphipathic Helix: An Untold Story; The Amphipathic Helix and HDL; Current History of HDL Structure; Current Thoughts on the Biomedical Implications of HDL; What Are Peptide Mimetics and Should I Care?; References; ApoA-I Mimetic Peptides: A Review of the Present Status. ApoA-I Mimetic Peptides Were Designed to Mimic a Plasma Apolipoprotein The Peptides Were Effective in a Large Number of Animal Models of Disease; The 4F Peptide Was Tested in Human Clinical Trials; Reconciling the Divergent Results from the Clinical Trials; Overcoming the Barrier of the High Cost of Production of Chemically Synthesized ApoA-I Mimetic Peptides; Determining the Mechanism of Action of Oral ApoA-I Mimetic Peptides; Other Peptides; Conclusions; References; Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux; Introduction; Reverse Cholesterol Transport Pathway. Apolipoprotein Mimetic PeptidesESP24218 Peptide; D-4F Peptide; L-4F Peptide; Retroinverso Peptides; 5A Peptide; ATI-5261 Peptide; Summary; References; ApoA-I Mimetic Peptides and Diabetes; Introduction; 4F Background; 4F and Diabetes; Conclusion; References; Apolipoprotein A-I Mimetic Peptides in Mouse Models of Cancer; Introduction; Inflammation and Lipoproteins in Cancer; ApoA-I and Ovarian Cancer; ApoA-I Mimetic Peptides as Cancer Therapeutics; ApoA-I Mimetic Peptides and Colon Cancer; Conclusions; References. Effects of ApoA-I Mimetic Peptide L-4F in LPS-Mediated InflammationIntroduction; LPS and Sepsis; HDL and LPS; ApoA-I and Sepsis; ApoA-I Mimetic Peptides 18A and 4F; ApoA-I Mimetic Peptide L-4F and LPS; ApoA-I Mimetic Peptide L-4F in Polymicrobial Septic Models; Efficacy of L-4F in Different Models of Atherosclerosis and Metabolic Syndrome (Diabetes) Could Be in Part Accounted for by Its Anti-endotoxin Property; References; Apolipoprotein Mimetics in the Amelioration of Respiratory Inflammation; Introduction; Genetic Deletion of ApoA-I; 4F Inhibits Airway Inflammation. Potential Mechanisms of Action Other Apolipoprotein Mimetics That Modulate Airway Inflammation; Novel Apolipoprotein Mimetics; References; Regulation of Macrophage Polarity by HDL, Apolipoproteins, and Apolipoprotein Mimetic Peptides; Introduction; Macrophage Polarization; Macrophage Heterogeneity and Atherosclerosis; HDL Composition and Function; Dysfunctional HDL; HDL-Associated S1P and Macrophage Phenotype; ABCA1 and Macrophage Polarization; HDL, Activating Transcription Factor, and Macrophage Polarization; Apolipoprotein A-I Mimetic Peptide Design. … (more)
- Publisher Details:
- Cham : Adis
- Publication Date:
- 2015
- Extent:
- 1 online resource, illustrations (chiefly color)
- Subjects:
- 572/.6
Medicine
Apolipoproteins
High density lipoproteins
Peptides
Lipids -- Metabolism
SCIENCE -- Life Sciences -- Biochemistry
Apolipoproteins
High density lipoproteins
Lipids -- Metabolism
Peptides
Apolipoproteins
Peptides
Lipid Metabolism
Medical -- Cardiology
Medical -- General
Cardiovascular medicine
Medicine: general issues
Biochemistry
Cardiology
Medical -- Biochemistry
Biochemistry
Electronic books - Languages:
- English
- ISBNs:
- 9783319173504
3319173502
3319173499
9783319173498 - Related ISBNs:
- 9783319173498
- Notes:
- Note: Includes bibliographical references.
Note: Online resource; title from PDF title page (Ebsco, viewed June 19, 2015). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.369809
- Ingest File:
- 01_354.xml